“While early weight loss [after] metabolic and bariatric surgery in adolescents with severe obesity has been established, there is a need to explore social factors,” Richard E. Boles, PhD, professor at the University of Colorado Anschutz Medical Center, said during a presentation. “We aimed to examine the relation of social vulnerability and BMI” through 10 years of follow-up.
Dr. Christopher Lieu, of the University of Colorado Cancer Center, spoke with GI Oncology Now about the upcoming liver cancer trials he has his eye on. He noted that a lot of research around treating metastatic liver cancer is now focused on immunotherapies, with the ultimate goal of having the therapies train the immune system to find, detect, and kill the cancer. Dr. Lieu also discussed the data from ESMO 2023 that he is most interested in seeing.
The industry also favored reputable scientists who were considered scientifically conservative, for generally wanting to see a larger body of evidence than their peers before reaching conclusions. Among them is Dr. Jonathan Samet, dean of the Colorado School of Public Health, who has a long history as an epidemiologist and researcher. A 1995 review produced by tobacco company Philip Morris concluded that his reputation "as an authority in pulmonary medicine and epidemiology" was "probably due at least in part to his scientific conservatism."
This second Colorado, said Jane Reusch, professor of endocrinology at the University of Colorado Anschutz Medical Campus, “doesn’t really look dissimilar to what’s found in Mississippi, Louisiana and Arkansas.”
What would liver doctors never do? These hepatologists at the University of Colorado School of Medicine get candid.
Research from the Colorado Department of Health and Environment states “airborne and dermal exposure to fentanyl does not represent a realistic threat to safety.” Also the University of Colorado’s Anschutz Medical Center published a paper regarding myths about fentanyl. One myth listed is that being near fentanyl causes “serious effects.”
While home birth is “available for people who are low risk,” Dr. Jessica Anderson, director of midwifery and women’s health services at the University of Colorado Anschutz Medical Campus, points to “people that shouldn’t or can’t birth out of the hospital,” such as those with medical conditions like high blood pressure or diabetes.
In a related commentary published in The New England Journal of Medicine, Satish K. Garg, MD, professor of medicine and pediatrics at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, and Sarit Polsky, MD, MPH, assistant professor of medicine and pediatrics at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, wrote that the trial revealed how a hybrid closed-loop system can be “safe and effective when customizable glucose targets within the pregnancy-specific target glucose range are used.” However, they said several questions were unanswered in the trial, including when hybrid closed-loop therapy should be initiated.
